The aforementioned results have exposed the fundamental inflammatory mechanisms involved in ET and have also identified SENP6 as a potentially efficacious gene therapy tool that could be further explored in the context of treating ET patients. This evidence concerns the gene SENP6 and essential thrombocythemia.